COMP <GO>
ZTS vs ONC // EV/EBITDA & P/E VALUATION
Zoetis Inc. (NYSE) VS. BeOne Medicines Ltd. (NASDAQ) • 15-METRIC TALLY: ZTS 8
— ONC 5
▲ EV/EBITDA & P/E VALUATION LEADER: ZTS
LAST: $79.72 (+1.17%) • MKT CAP: $32.56B
valuation
10.3x
LAST: $370.33 (-0.33%) • MKT CAP: $42.25B
valuation
63.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTS VS. ONC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZTS | ONC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.80% | 87.50% | -15.70 | ONC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.70% | 10.50% | +15.20 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.3x | 63.9x | -53.60 | ZTS | /valuation <GO> |
| Free Cash Flow Yield | 7.01% | 2.23% | +4.78 | ZTS | /fcf-yield <GO> |
| Operating Margin | 34.40% | 8.40% | +26.00 | ZTS | /operating-margins <GO> |
| Net Profit Margin | 28.20% | 5.40% | +22.80 | ZTS | /net-margins <GO> |
| Revenue Growth (YoY) | 2.30% | 40.20% | -37.90 | ONC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.53 | 6.68 | -2.15 | ONC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | ONC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 53.6 | +3.00 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.98 | +0.01 | ZTS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 123.6x | -112.30 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $32.56B | $42.25B | -$9.69B | ONC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZTS REV | ONC REV | ZTS GROSS % | ONC GROSS % | ZTS FCF | ONC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.47B | $5.34B | 71.8% | 87.5% | $2.28B | $941.7M |
| FY 2024 | $9.26B | $3.81B | 70.6% | 84.4% | $2.30B | -$633.3M |
| FY 2023 | $8.54B | $2.46B | — | — | $1.97B | -$1.27B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTS // BETA 0.99
ONC // BETA 0.98